Ashland (ASH)

• Market cap: $2.27B
• 1 day: 0.20%
• 5 days: 1.95%
• 1 month: -3.21%
• 3 months: -21.73%
• 6 months: -36.39%
• Year to date: -28.18%
• 1 year: -48.81%
• 5 years: -18.76%
• 10 years: -61.91%
• Sector: Materials
• Industry: Specialty Chemicals

About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.

Employees: 3,200

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

4.0% more ownership

Funds ownership: 90.47% [Q3] → 94.47% (+4.0%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]

6% less repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 127

7% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 58

3% less funds holding

Funds holding: 364 [Q3] → 353 (-11) [Q4]

17% less capital invested

Capital invested by funds: $3.84B [Q3] → $3.18B (-$659M) [Q4]

62% less call options, than puts

Call options by funds: $2.81M | Put options by funds: $7.38M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $58 16% upside
• Avg. target: $66 32% upside
• High target: $74 48% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

JP Morgan Jeffrey Zekauskas 28% 1-year accuracy 11 / 40 met price target	34% upside $67	Overweight Maintained	6 May 2025
UBS Joshua Spector 36% 1-year accuracy 20 / 56 met price target	48% upside $74	Buy Maintained	1 May 2025
Wells Fargo Michael Sison 23% 1-year accuracy 13 / 56 met price target	16% upside $58	Overweight Maintained	9 Apr 2025